Gonadal steroids differentially regulate the messenger ribonucleic acid expression of pituitary orexin type 1 receptors and adrenal orexin type 2 receptors.
Hypothalamic prepro-orexin as well as pituitary and adrenal orexin receptors are gender-specifically expressed. To assess the regulation by gonadal steroids, we investigated the effect of 17beta-estradiol in female and of testosterone in male rats on prepro-orexin and orexin receptor mRNA expression. Rats were either sham-operated or gonadectomized and subsequently treated with placebo, 17beta-estradiol, or testosterone for 21 d. Tissue mRNA levels of prepro-orexin, orexin type-1 (OX(1)), and orexin type-2 (OX(2)) receptors were measured using quantitative real-time RT-PCR. In female rats, pituitary OX(1) receptor mRNA levels were increased 12-fold after ovariectomy compared with sham- operated rats. The increase of pituitary OX(1) receptor mRNA was inhibited by treatment with 17beta-estradiol. Adrenal mRNA levels of OX(2) receptors in ovariectomized rats were increased 2-fold compared with sham-operated rats and were also reduced by treatment with 17beta-estradiol. In male rats, orchidectomy increased the mRNA levels of pituitary OX(1) receptors compared with sham-operated rats. In contrast, adrenal OX(2) receptor mRNA was reduced after orchidectomy. Testosterone treatment reversed the effect of orchidectomy on pituitary OX(1) and adrenal OX(2) receptors. In the hypothalamus, no differences were found in the mRNA levels of prepro-orexin, OX(1), and OX(2) receptors between sham-operated, placebo-treated, and steroid-treated female or male rats. Our results indicate that gonadal steroids differentially regulate pituitary OX(1) receptors and adrenal OX(2) receptors in male and female rats and may contribute to specific sex- dependent neuroendocrine and endocrine actions of orexins.
Jöhren
Olaf
O
Institute of Experimental and Clinical Pharmacology and Toxicology, University Clinic Lübeck, D-23538 Lübeck, Germany. Joehren@medinf.mu-luebeck.de
Brüggemann
Norbert
N
Dendorfer
Andreas
A
Dominiak
Peter
P
D000818:Animals; D001835:Body Weight; D004958:Estradiol / Q000097:blood / Q000494:pharmacology*; D005260:Female; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology; D012739:Gonadal Steroid Hormones / Q000097:blood / Q000494:pharmacology*; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D047908:Intracellular Signaling Peptides and Proteins; D008297:Male; D009479:Neuropeptides / Q000235:genetics; D009919:Orchiectomy; D064446:Orexin Receptors; D000068797:Orexins; D010052:Ovariectomy; D010913:Pituitary-Adrenal System / Q000502:physiology; D016133:Polymerase Chain Reaction; D011498:Protein Precursors / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D043562:Receptors, G-Protein-Coupled; D018013:Receptors, Neuropeptide / Q000235:genetics*; D012727:Sex Characteristics; D013739:Testosterone / Q000097:blood / Q000494:pharmacology*
D012739:Gonadal Steroid Hormones; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D064446:Orexin Receptors; D000068797:Orexins; D011498:Protein Precursors; D012333:RNA, Messenger; D043562:Receptors, G-Protein-Coupled; D018013:Receptors, Neuropeptide; D013739:Testosterone; D004958:Estradiol